Breaking: Vax Dosing Pseudoscience Exposed in NY Study!

Implications could go far beyond the efficacy of the Covid-19 vaccine in children. Adults and children alike may be in danger from the unscientific practice of dosing mRNA vaccines by age.

Mar 02, 2022

A preprint study comparing Covid infection and hospitalization rates in vaccinated vs. unvaccinated children appears to confirm my exclusive report, published Feb. 13 on Substack, that dosing the mRNA Covid-19 vaccines by age is pure quackery and quite possibly dangerous.

The objective of the New York-based study was to estimate the efficacy of the Pfizer vaccine in children ages 5 to 17 during the high infection months of December 2021 and January 2022. Researchers analyzed Covid-19 infection and hospitalization rates in vaccinated vs. unvaccinated children and found that vaccine efficacy faded rapidly for all children but especially for those in the 5 to 11 age group. By week five, the Covid-19 vaccine was found to be only 12 percent effective in preventing infection for children in this age group. By week six, vaccine efficacy was trending negative, with fully vaccinated children under the age of 12 more likely to contract the virus than the unvaccinated.

The authors noted that 12-year-old children in their study had the highest vaccine efficacy of all youths and suggested this might be due to their small size relative to the dose they received. Children ages 12 to 17 receive the adult dose of the Pfizer vaccine, while children 5 to 11 receive one-third the adult dose.

From the Study:

“The finding of markedly-lower VE [vaccine effectiveness] against infection for children 11 years compared to those 12 and 13 years, despite overlapping physiology, suggests lower vaccine dose may explain lower 5-11 years VE. Children 12 years had the highest VE of all ages, potentially due to being small size relative to dose and more recent vaccination (by 6 weeks on average) than those 13-17 years. This gap suggests a threshold effect between the two BNT162b2 [Pfizer] vaccine doses and need for study of numbers of doses, amount per dose, dose timing, and/or antigens targeted for children 5-11 years.”

In my prior Substack article, titled “mRNA Vax Pseudoscience: Dosing by Age, Not Weight,” I noted the lack of science behind Pfizer’s decision to dose these mRNA injections by age. I pointed out that children who are the same age can vary widely in their physiology. For that reason, drug dosages for children usually are determined by weight. Dosing decisions can also be influenced by body size, lab values, stage of illness, and/or stage of treatment.

I also noted that these Covid-19 injections have far more in common with gene therapy drugs than they do with traditional vaccines, as medical doctors like Robert Malone have explained. So, I reviewed the dosing regimens for gene therapy drugs. I found none that were dosed by age. When dosing varied, gene therapy drugs were dosed by either weight or lab values:

· Kymriah – for acute lymphoblastic leukemia in children and young adults, is dosed by weight

· Yescarta – for large B-cell lymphoma or follicular lymphoma in adults, is dosed by weight

· Zolgensma – for spinal muscular atrophy in children under two, is the same dose for everyone

· Breyanzi – for B-cell lymphoma in adults, is dosed based on the number of chimeric antigen receptor (CAR)-positive viable T-cells

· Abecma – for multiple myeloma in adults, is dosed the same as Breyanzi

· Lumakras – for lung cancer in adults, is the same dose for everyone “until disease progression or unacceptable toxicity”

It seems likely that both Pfizer and Moderna decided purely for financial reasons to create one-size-fits-all doses of their Covid-19 vaccines across large age brackets. Standard doses are far more profitable than having to design, test, package, and administer different dosages based on weight or other physical factors.
The implications of the finding from this New York study – of maximum vaccine effectiveness in 12-year-olds who received the adult dose – could extend well beyond the issue of vaccine efficacy in children. The arbitrary dosing of these experimental gene therapy injections by age instead of weight or other biological factors could affect both efficacy and safety in vaccine recipients of all ages.
We already know, for example, that to date the CDC’s Vaccine Adverse Events Reporting System (VAERS) has recorded more than twice as many adverse events from the Covid-19 vaccines in females vs. males (735, 140 vs. 348,114). [1] Is this apparent greater sensitivity to the side effects of the vaccine in females related in any way to the fact that females weigh less, on average, than males and therefore may have stronger reactions, both positive and negative, when they receive the same dose as heavy males?
We also know that Covid-19 is more deadly in males than females and that the vaccines have done little to alter that equation. In highly vaccinated countries like England that also collect and publish comprehensive weekly data, males are still succumbing to death from Covid in much higher numbers than females.[2] Are vaccinated males dying from Covid because for heavier males the standard adult dose is too low to enable sufficient antibody production, even in the short-term? One study published last fall found that higher body mass index was associated with lower titers of spike IgG antibodies against SARS-CoV-2 in men but not in women.[3]
We also know that in the ongoing clinical trial of the Covid-19 vaccine in children six months to five years old, Pfizer so far has reported that the two-dose regimen – with a vaccine that is one-third the dose of children 5 to 11 – met the antibody production target in children up to two years old but failed in the older toddlers and preschoolers. (Pfizer currently is testing a third dose with all children in the trial.) This outcome once again points to a sensitivity that most likely is influenced by weight. Will any approved vaccine for this age group cause the most harm, on average, to the lightest children in the group and show the least efficacy in the heaviest?
These questions demand immediate answers. To be sure, weight is not the only factor that influences how individuals respond to these vaccines. For example, we know that high testosterone in teen boys and young men places them at unacceptably high risk of vaccine-induced myocarditis. It is likely that weight and testosterone levels are just two of numerous factors that influence whether individuals derive any short-term benefit or suffer any long-term damage from these injections.
For so many reasons, these dangerous and ineffective products should never have been authorized. Their arbitrary dosing by age is yet another reason that parents should steer clear of this dangerous experiment, and adults of all ages should be wary.
My prior article is here:

mRNA Vax Pseudoscience: Dosing by Age, Not Weight (substack.com)

The New York study is here:

Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant | medRxiv

If you like this article, please share it with your friends, family, and colleagues.

Please scroll down past the references to post a comment. I am really enjoying hearing your thoughts, even if I don’t always have time personally to respond.

Kids, Covid, and Covid Vaccines

Discussion about this post